Susanne Weindler

SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2

A. Addeo, M. Joerger, S. Rothschild, 2020, Cancer Immunology, Immunotherapy.

Methylation profiling in individuals with Russell–Silver syndrome

C. Boerkoel, S. Langlois, D. Metzger, 2010, American journal of medical genetics. Part A.